BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8920918)

  • 1. Functional analysis of vitamin D response elements in the parathyroid hormone gene and a comparison with the osteocalcin gene.
    Hawa NS; O'Riordan JL; Farrow SM
    Biochem Biophys Res Commun; 1996 Nov; 228(2):352-7. PubMed ID: 8920918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor.
    Liu SM; Koszewski N; Lupez M; Malluche HH; Olivera A; Russell J
    Mol Endocrinol; 1996 Feb; 10(2):206-15. PubMed ID: 8825560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor.
    Mackey SL; Heymont JL; Kronenberg HM; Demay MB
    Mol Endocrinol; 1996 Mar; 10(3):298-305. PubMed ID: 8833658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
    Russell J; Ashok S; Koszewski NJ
    J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turning a negative into a positive: vitamin D receptor interactions with the avian parathyroid hormone response element.
    Koszewski NJ; Ashok S; Russell J
    Mol Endocrinol; 1999 Mar; 13(3):455-65. PubMed ID: 10077002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene.
    Darwish HM; DeLuca HF
    Arch Biochem Biophys; 1999 May; 365(1):123-30. PubMed ID: 10222046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of binding of the 1,25-dihydroxyvitamin D3 receptor to positive and negative vitamin D response elements.
    Darwish HM; DeLuca HF
    Arch Biochem Biophys; 1996 Oct; 334(2):223-34. PubMed ID: 8900396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
    Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
    J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an enhancer required for 1,25-dihydroxyvitamin D3-dependent transactivation of the rat osteocalcin gene.
    Sneddon WB; Demay MB
    J Cell Biochem; 1999 Jun; 73(3):400-7. PubMed ID: 10321839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells.
    Pavlin D; Bedalov A; Kronenberg MS; Kream BE; Rowe DW; Smith CL; Pike JW; Lichtler AC
    J Cell Biochem; 1994 Dec; 56(4):490-501. PubMed ID: 7890807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors.
    Liu M; Freedman LP
    Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.
    Sneddon WB; Bogado CE; Kiernan MS; Demay MB
    Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
    Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
    Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.